Log in to your Inderes Free account to see all free content on this page.

Vimian Group

32.52 SEK

+1.43 %

Less than 1K followers

VIMIAN

NASDAQ Stockholm

Health Care Providers

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

+1.43 %

+7.19 %

+8.54 %

+13.63 %

-22.94 %

-14.98 %

+26.74 %

-

-58.49 %

Vimian Group is a group operating in animal health. The company, through its subsidiaries, delivers pharmaceuticals and technical solutions to veterinarians, laboratories and pet owners. The products include, for example, pharmaceuticals with associated clinical research and digital platforms for veterinary clinics. The company operates on a global level with headquarters in Stockholm.

Market cap

17.21B SEK

Turnover

2.07M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

12.2.

2026

Annual report '25

29.4.

2026

Interim report Q1'26

29.4.

2026

General meeting '26

All

Webcasts

Press releases

ShowingAll content types

Regulatory press release12/30/2025, 4:30 PM

Change in the number of shares and votes in Vimian

Press release12/23/2025, 7:05 AM

Vimian acquires I-Vet to strengthen its companion animal diagnostics offering

Regulatory press release12/22/2025, 8:30 PM

Vimian has resolved to issue and repurchase additional class D shares, class E1 2025 shares, class E2 2025 shares, and class E3 2025 shares as part of its long-term incentive program 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release11/28/2025, 4:30 PM

Change in the number of shares and votes in Vimian

Regulatory press release11/24/2025, 6:15 AM

Vimian Group AB (publ) appoints Alireza Tajbakhsh as CEO

Regulatory press release10/27/2025, 6:00 AM

Vimian has resolved to issue and repurchase class D shares, class E1 2025 shares, class E2 2025 shares, and class E3 2025 shares as part of its long-term incentive program 2025

Vimian Group, Audiocast, Q3'25

Webcast10/22/2025, 7:00 AM

Vimian Group, Audiocast, Q3'25

Regulatory press release10/22/2025, 5:45 AM

Vimian’s Interim Report for the third quarter of 2025

Press release10/13/2025, 8:00 AM

Invitation to Vimian’s Interim Report for the third quarter of 2025

Regulatory press release9/23/2025, 8:00 AM

Nomination Committee for Vimian’s 2026 Annual General Meeting

Regulatory press release8/29/2025, 11:03 PM

Superior Court of Delaware awards Vimian USD 40.2 million in indemnification dispute

Regulatory press release7/31/2025, 3:30 PM

Change in the number of shares and votes in Vimian

Vimian Group, Audiocast, Q2'25

Webcast7/18/2025, 7:00 AM

Vimian Group, Audiocast, Q2'25

Regulatory press release7/18/2025, 5:45 AM

Vimian’s Interim Report for the second quarter of 2025

Regulatory press release7/17/2025, 4:30 PM

Vimian Group AB (publ) CEO Patrik Eriksson steps down

Press release7/7/2025, 11:00 AM

Invitation to Vimian’s Interim Report for the second quarter of 2025

Regulatory press release6/30/2025, 3:30 PM

Change in the number of shares and votes in Vimian

Press release6/17/2025, 3:30 PM

Subscription period for Vimian’s incentive program 2022-2025 has commenced

Press release6/13/2025, 5:00 AM

Vimian Group expands its veterinary dental offering through the acquisition of a leading provider of a dental sealant product

Regulatory press release6/11/2025, 10:30 AM

Press release from the Exraordinary General Meeting in Vimian Group AB (publ) on 11 June 2025

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.